|
Vijay B. Samant age 53 has been President and Chief Executive Officer of Vical since he joined us in November 2000. Previously he held various positions at Merck from 1977 to 2000. From 1998 to 2000 he was Chief Operating Officer of the Merck Vaccine Division. From 1990 to 1998 he served in the Merck Manufacturing Division as Vice President of Vaccine Operations Vice President of Business Affairs and Executive Director of Materials Management. From 1977 to 1990 Mr. Samant held a variety of positions of increasing responsibility in manufacturing process engineering production planning and control business development and loss prevention in several Merck operating divisions. Mr. Samant holds a bachelor's degree in chemical engineering from the University of Bombay India an M.S. degree in chemical engineering from Columbia University and an M.B.A. degree from the Sloan School of Management at the Massachusetts Institute of Technology. Mr. Samant is a director of the Aeras Global TB Vaccine Foundation a not-for-profit organization working to develop tuberculosis vaccines serves on the Project Management Subcommittee of the IAVI and is on the Board of Trustees of the National Foundation for Infectious Diseases. | 